I don't think anything is going to move this stock up much until they dose the first patient and give us a time line for the vaccine trial.....I don't think they should try to list NGIO until they get the shareprice up some....just my opinion.
There are are other things that could move the stock, I just think getting the trial started is the nearest term catalyst.